The NHS will divert billions of pounds from essential services to pay for new medicines, under the terms of the US-UK trade deal agreed in December, which could lead to more than 200,000 excess deaths, analysis has found. Ministers have defended the deal as a way of helping British drug exports avoid US tariffs and giving patients access to vital medication, but critics accuse the Labour party of caving into pressure from Donald Trump. Lucy Hough speaks to columnist Aditya Chakrabortty – watch on YouTube. Help support our independent journalism at <a href="https://www.theguardian.com/infocus">theguardian.com/infocus</a>
